Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To estimate antitumor activity of abiraterone acetate, as measured by the 6 months clinical benefit rate (CBR) in molecular apocrine HER2-negative locally advanced or metastatic breast cancer.
Critère d'inclusion
- Molecular apocrine locally advanced or metastatic breast cancer